Skip to main content

How to design and implement a university-based COVID-19 testing programme? An evaluation of a novel RT-LAMP COVID-19 testing programme in a UK university



Little is known about how asymptomatic testing as a method to control transmission of COVID-19 can be implemented, and the prevalence of asymptomatic infection within university populations. The objective of this study was to investigate how to effectively set-up and implement a COVID-19 testing programme using novel reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) technology and to quantify the scale of asymptomatic infection on a university campus.


An observational study to describe the set-up and implementation of a novel COVID-19 testing programme on a UK university campus between September and December 2020. RT-LAMP testing was used to identify asymptomatic cases.


A total of 1,673 tests were performed using RT-LAMP during the study period, of which 9 were positive for COVID-19, giving an overall positivity rate of 0.54%, equivalent to a rate in the tested population of 538 cases per 100,000 over the duration of testing. All positive tests were found to be positive on RT-PCR testing, giving a false positive rate of 0%.


This study shows that it is possible to rapidly setup a universal university testing programme for COVID-19 in collaboration with local healthcare providers using RT-LAMP testing. Positive results were comparable to those in the local population, though with a different peak of infection. Further research to inform the design of the testing programme includes focus groups of those who underwent testing and further interrogation of the demographics of those opting to be tested to identify potential access problems or inequalities.

Peer Review reports


First reported in December 2019, COVID-19 spread rapidly around the globe. It has caused widespread disruption, with countries implementing different measures to control the virus and limit its impact on healthcare and economies. There has often been a balancing act between keeping facilities and amenities open and controlling the transmission of the virus [1]. This has been particularly debated in the context of students studying in universities [2], where there have been calls for students to avoid universities [3] and the UK Independent SAGE Group (a group providing independent scientific advice to the UK government and public on COVID-19) advocated testing of university staff and students on arrival at university to identify pre-symptomatic or asymptomatic cases [4].

Asymptomatic transmission

Although studies have found 17–20% of COVID-19 infections are asymptomatic across all population groups [5], this proportion rises significantly in younger and healthier groups [6]. Research into other coronaviruses, namely SARS and MERS, suggested that presymptomatic transmission was not a significant contributor to infection rates [7]. However, with COVID-19 infections, it has been shown that cases are also able to transmit the virus before they develop symptoms [8]. This has been particularly concerning as initial methods to control the virus had relied on isolation of people who were displaying symptoms. Estimates have suggested that up to 30% of COVID-19 infections could stem from asymptomatic transmission [9], leading to a focus on mass testing in asymptomatic populations in order to isolate those cases to break the chain of transmission. At the time of this study, national policy in England was that only people displaying symptoms, or those who had been advised by a healthcare professional, were eligible for COVID-19 testing using RT-PCR tests [10]. Rapid antigen tests were not widespread, with use trialled from August 2020 and limited to care home workers and hospital workers [11].

University transmission

The return of university students to campuses in both Europe and America coincided with a spike in transmission in many countries. Correlations were seen between rises in COVID-19 cases in counties in America with increasing numbers of students within the local population [12]. Whilst the university population tend to be in younger age groups where the fatality rate from COVID-19 is much lower [13], there is often mixing with the local population: the CON-QUEST survey at University of Bristol found that around 40% of student contacts were with individuals not affiliated with the university [14]. This suggests that outbreaks in students can easily spread to older adults and other higher risk groups in the wider community.

University testing programmes

A number of mitigation measures have been suggested and modelled [15], with some universities in the UK implementing their own asymptomatic testing programmes to reduce COVID-19 transmission on campus, although not recommended by the UK government at the time. Examples of this include the University of Cambridge who used pooled weekly RT-PCR tests in their “Stay Safe Cambridge Uni” programme [16], and the University of Nottingham who had a weekly testing programme in addition to a programme of rolling sentinel surveillance testing sessions in their “Test to Protect” scheme [17]. The testing programme at the University of East Anglia was credited with nearly eliminating COVID-19 on campus [18], and University of Southampton implemented novel reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) testing on saliva samples to test asymptomatic staff and students [19].

This article details the design and set-up of a university testing programme to identify asymptomatic cases of COVID-19 within the staff and student population of the University of Leicester and to isolate and perform contact tracing within a timely manner. The rationale of this was to reduce transmission of COVID-19 and prevent outbreaks both in the university population and the wider community, enabling campus to remain open throughout the semester. Aims and objectives of the programme are detailed in Fig. 1.

Fig. 1
figure 1

Aims and objectives of the university testing programme for COVID-19


Programme set up

The asymptomatic testing programme at the University of Leicester was designed and set up between July and September 2020, with the first participants being screened in September 2020. A steering group from within the University were able to capitalise on strong links between the University, the local hospital (University Hospitals of Leicester NHS Trust), and the local public health teams (Leicester City Council and Leicestershire County Council). Due to the rapid timeframe involved there was a need to simplify processes and use existing systems and it was not possible to trial the process with a pilot programme prior to the return of students to campus. Predicted uptake was unknown but preparations were made for up to 80% of staff and students to participate in testing. No restrictions were placed on frequency of testing. The testing programme received attention in local media and was included in communications to students enrolling at the university. To continuing students and staff, they were informed of the testing programme by email and details were also included in the university webpages providing information on COVID-19.

LAMP testing, technique used, specificity and sensitivity

The testing programme set up at the University of Leicester used reverse transcriptase loop-mediated isothermal amplification (RT-LAMP). Contrary to RT-PCR, LAMP amplification [20] is performed at a single temperature on a basic thermocycler and uses reagents distinct from RT-PCR. Following increased demand and delays associated with centralised RT-PCR testing during the COVID-19 pandemic, it has been suggested that alternative testing modalities are required in the pandemic response [21]. An additional strength of RT-LAMP testing is that RT-LAMP assays use a longer region of the target DNA/RNA than real-time RT-PCR assays so the probability of detecting a fragmented target is lower, and it has been found to give results within minutes [22]. RT-LAMP is therefore a valuable diagnostic tool for SARS-CoV-2.

Swabs of the oropharyngeal and nasopharyngeal cavities were taken using Miraclean swabs placed into PrimeStore Molecular Transport Medium for viral inactivation and RNA stabilisation at room temperature [23]. Within a 24-h period, total nucleic acid extraction was followed by RT-LAMP against a single target. Total nucleic acid extraction to RT-LAMP was performed in-house using medium throughput automation and performed following quality standards, with guidance provided by Leicester Molecular Diagnostic Laboratory. The RT-LAMP assay implemented [24] was validated in-house using residual RNA from University Hospital Leicester (UHL) NHS inpatient swab samples with corresponding RT-PCR Ct value [25]. Furthermore, screening was performed to ISO 15189:2012 standards, using NHS IT infrastructure. Insufficient sample collection or sample extraction were identified as a major potential source of false negative results prior to testing commencing. To mitigate this, an internal control (total RNA) was used for each sample.

Set up of testing centre and transport to laboratory

Due to safety concerns relating to the presence of guanidine thiocyanate in the molecular transport media, testing was carried out by participants in a supervised testing centre rather than participants being provided with testing kits. A testing centre was set up in a repurposed area of a building on the university campus. Eight individual booths were constructed to allow for simultaneous sample collection (see Supplementary Materials). Two sessions were run per day, each of three hours’ duration, with ten minutes allowed per appointment. This was adequate for sample collection and cleaning of the booth. Samples were transported to the laboratory at the end of each testing session. Sample batches arrived at the laboratory for same day RNA extraction and RT-LAMP. Data analysis and results notification followed (same day or next day depending on time of sample batch delivery): a turn-around time (sample to results) of under 48 h. An additional ‘pop-up’ testing centre was also implemented after seven weeks to improve access to testing and was located at a site around four kilometres from main campus, closer to student accommodation, with set up similar to the main testing centre.


To facilitate transfer of results between laboratories and onwards to the national COVID-19 surveillance system and participants, the IT system within the local National Health Service (NHS) hospital was used. All participants were registered with a local primary care practice, on either a temporary or permanent basis, introducing a lead time of around seven days for registration before participants could request an appointment for testing. The practice generated requests for the hospital pathology system in order to process participants’ samples upon the booking of an appointment at the testing centre, and corresponding labels for samples were ready for participants to collect upon their arrival at the testing centre. Health data was kept within the NHS, and the practice informed participants of their results via SMS. No personal data relating to test results was held by the university.

Booking system

The booking system utilised local IT systems which were already in place, using Microsoft 365. Appointment slots were opened up to a week in advance, but no sooner than 48 h in advance, allowing time for the primary care practice to process the pathology request and for printing of the corresponding pathology request. Data relating to booking of appointment slots was held within the University booking system.

Confirmatory RT-PCR test in hospital for positive samples

To prevent false positive test results resulting in unnecessary isolation by participants, any tests returning as positive after the RT-LAMP test were transferred to the main hospital pathology laboratories for a confirmatory RT-PCR test. Participants were informed immediately of a positive RT-LAMP test by the university medical centre staff and advised to isolate pending the confirmatory test to prevent any delay in isolation. If the RT-PCR test was also positive, the primary care practice was informed at the earliest opportunity. They then informed the participant by telephone and provided appropriate public health advice, as well as giving advice on when to seek further medical advice. This result was also entered into the national Test and Trace system to allow contact tracing follow-up. Negative tests were communicated to primary care after RT-LAMP testing and results were then communicated to participants via SMS with public health advice. The steps involved in the process are detailed in Fig. 2.

Fig. 2
figure 2

Steps in the testing process

Time period of data collection

Appointments were held between 28 September and 18 December. These were initially daily, but moved to twice-weekly from 30 November due to decreased bookings, likely due to students leaving campus prior to the Christmas break and the concurrent national lateral flow testing introduced for students to travel safely.

Data analysis

Data included for analysis in this paper are testing uptake, indicated by time period (weekly) and by location of swab collection, and the number of repeat bookings by individual participants. Quality assurance data are reported, namely the time of test to result and the internal control measure of total RNA. Positivity rate is also reported and refers to the proportion of tests returning a positive result. This can be a proxy measure of the infection rate in the population but does not provide the true infection rate.


Testing uptake and positivity rate

Testing was available to all staff and students attending campus. A total of 1673 tests were performed during the study period. The total number of staff and students eligible for testing was initially around 10,000 people, although numbers attending campus decreased over the testing period due to implementation of national COVID-19 restrictions and students returning home as learning continued to be delivered remotely.

Data included the number of positive tests and cumulative number of tests, allowing calculation of a positivity rate. An additional testing location closer to student accommodation was operational from Week 8. Weekly data can be seen in Table 1.

Table 1 Number of tests per week by location and number of positive tests per week

During the period under investigation, there were 9 positive tests from a total of 1,673 tests. This gave an overall positivity rate of 0·54%. This is equivalent to a rate in the tested population of 538 cases per 100,000 over the duration of testing. The highest number of positive tests were returned at the start of this period, with four positive tests in the second week of testing (in early October). The time from test to result was usually between one and two working days depending on the requirement for confirmatory testing.

False positive tests

Of the 1,673 tests conducted, nine tests were positive on RT-LAMP testing. These were all found to be positive on RT-PCR testing in the hospital laboratory, giving a false positive rate of 0%. Using the internal quality control of total RNA resulted in one sample being reported negative for total RNA (and SARS-CoV-2) and so a re-swab was requested, which was also negative.

Repeat bookings

Testing was available for staff and students of the university as often as they requested it. Data for repeat bookings were generated by the number of bookings made by a specific email address. This is shown in Table 2. It can be seen that the majority of people booking a test (56%) used a unique email address to book one test. In a small minority of cases (5%), the same email address was used for more than four bookings.

Table 2 Number of repeat bookings made, by individual email address


Main findings of the study

The results indicate that the level of asymptomatic COVID-19 infection within the university population during the autumn term was equivalent to 538 cases per 100,000 of those tested. For comparison, national coronavirus data on the number of infections in the local authority are available [26], though this is from symptomatic testing and calculated on a weekly basis, making direct comparisons difficult. Between 23 October and 10 December, the number of incident cases of COVID-19 infection ranged from 217 to 525 per 100,000 in Leicester City. However, this showed a different pattern to the positive cases found in the university testing programme: infection rates in Leicester City increased from 23 October and peaked on 19 November, whereas the university testing programme showed a peak in the initial testing period, likely due to the convergence of students from many areas of the country onto one site, and was also observed at two other UK universities [27].

The absence of false positive tests from this programme demonstrates the value and usability of RT-LAMP as a molecular diagnostic tool for the detection of SARS-CoV-2 in an asymptomatic population. The internal control (total RNA) used to mitigate the number of false negatives, with only one individual requiring a repeat sample, showed that the method of sample extraction was also a feasible method of testing. These findings indicate that the accuracy of RT-LAMP can help to prevent harms from misdiagnosis or uncertain results.

This study describes two novel aspects of mass testing for asymptomatic COVID-19 infection: it shows that it is possible to rapidly set-up and implement a university testing programme for asymptomatic staff and students, and it shows that RT-LAMP testing gives comparable results to RT-PCR when examining those who test positive on RT-LAMP, with RT-LAMP providing results faster than RT-PCR testing. If it is decided to move towards a model whereby COVID-19 is viewed as an endemic, rather than pandemic, infection, it is likely that mass testing will remain a key tool in the armoury of measures to prevent widespread infection and disruption. This paper shows policymakers that a model of asymptomatic testing is feasible and palatable for staff and students on a UK university campus.

Strengths and weaknesses of the study

A priority of the programme was that it should facilitate contact tracing and reduce onward transmission of COVID-19. Having a confirmatory RT-PCR test enabled positive samples to enter the national surveillance system and acted as a safety net if participants chose not to inform the university of the positive test. If participants informed the university of a positive test, support was available in the form of welfare checks, support with food and laundry, and a helpline for those who needed it.

Using an existing booking system rather than a bespoke system restricted the data that could be collected. As a result, there is no linked demographic data to describe the characteristics of those tested such as the proportions of staff and students receiving tests, the age and ethnicity of participants, and their location. This limits the generalisability of the results. Similarly, a significant limitation of the study was that there was no concurrent behavioural insight research, or research into the acceptability of the testing processes and procedures. This may have provided reasons for the decline in testing as well as testing behaviours.

The testing on campus was carried out alongside a rapidly changing national landscape with regards to testing, contact tracing and intense debate over the role of universities in the increasing rates of COVID-19 infection. A new policy relating to university students being offered two lateral flow tests prior to their leaving campus at the end of term may have impacted on the uptake of the university’s own tests. An additional aspect of the programme that may have affected uptake was the requirement to register with the local university health practice in order to be tested. Although registration was available on a temporary basis, and solely for the test, it is possible that this deterred some as they erroneously believed that this meant they could not continue to receive care from their usual family doctor.

Strengths and weaknesses in relation to other studies

Asymptomatic testing was conducted in Liverpool from 6 November to 9 December 2020 in a pilot of community testing. The interim evaluation report [28] revealed that in lateral flow testing, a positivity rate of 0.73% was found among the asymptomatic population. This is higher than the rate of 0.54% found in this study, though the population tested in Liverpool included a wider range of age groups, and the pilot used lateral flow testing rather than RT-LAMP, which have different sensitivity rates.

From the trends in the bookings over time, it was clear that after an early peak in demand, this steadily dropped over the course of the university term. This was seen to an extent in a feasibility pilot conducted at the University of East Anglia which saw high initial drop-out [29]. This may show a fatigue effect or lack of engagement, but may also reflect the trends in student occupancy falling in university accommodation due to students returning home as most teaching remained online. This level of occupancy was not captured by the study, giving some uncertainty over the denominator population.

Future research

Further evaluation of the testing programme could utilise the criteria used for national screening programmes [30]. Although the programme failed to meet several criteria to classify as a screening programme, such as the RT-LAMP test not yet being validated for SARS-CoV-2 and no randomised control trials, the test appeared to be acceptable to a proportion which may strengthen the case for minimally invasive tests being used for screening programmes as far as possible to increase uptake. A nuance of the university testing programme is that it focuses on the health of the wider population rather than individuals, in contrast to most recognised screening programmes.

Over half of the registrations for a COVID-19 test through the university testing system came from an email address which only registered for one test. Potential reasons for this include the test having a novelty value or being unacceptable to the population, or a belief that a negative test negated the need for further testing. There was a small number of individuals who registered for over four tests. Further research would be needed to examine the potential reasons for this.

Finally, a key limitation of this study is that it is not possible to say whether the asymptomatic testing programme contributed to limiting the rate of COVID-19 transmission on campus. This study was not designed to evaluate the frequency of testing or coverage of the target population required from a testing programme to effectively reduce transmission. Additional data such as individual case and contact follow-up would be required in order to ascertain whether the testing resulted in chains of transmission being broken. The testing programme is a small part of wider disease control with many complex elements, and so attempting to single out the effectiveness of one aspect of this would be open to many sources of confounding.


This paper is the first to report prevalence of asymptomatic COVID-19 infection within a UK university population using RT-LAMP as a molecular diagnostic tool. With the publication of data from other universities, a richer picture will develop of the true extent of COVID-19 infection within university populations. It provides a comparison with the reported epidemiological data from the local community, which is rarely reported in other papers discussing COVID-19 infection in university populations.

This paper shows that it is possible to rapidly set up a universal university testing programme for COVID-19 in collaboration with local healthcare providers, and that RT-LAMP is an acceptable diagnostic tool. It details some of the key aspects of setting up such a programme and outlines the strengths and limitations of the programme implemented, providing lessons learned for others who wish to implement a similar testing programme for COVID-19 or other infectious diseases. Combined with existing evidence, our paper shows that comprehensive testing programmes can feasibly include large groups of the community who may not access standard testing services, and make use of novel technology.

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.



Middle East respiratory syndrome


National Health Service


Reverse transcriptase loop-mediated isothermal amplification


Reverse transcriptase polymerase chain reaction


Scientific Advisory Group of Experts


Severe acute respiratory syndrome


  1. Pronk NP, Kassler WJ. Balancing health and economic factors when reopening business in the age of COVID-19. J Occup Environ Med. 2020;62(9):e540–1.

    Article  CAS  Google Scholar 

  2. Wrighton MS, Lawrence SJ. Reopening colleges and universities during the covid-19 pandemic. Ann Intern Med. 2020;173(8):664–5.

    Article  Google Scholar 

  3. Ferguson DHT. UK university reopenings risk ‘public health crisis’, academics warn. The Guardian. 2020;2020:29.

    Google Scholar 

  4. SAGE I. Consultation statement on safe return to universities 2020. Available from: [updated 20 August 2020].

  5. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17(9): e1003346.

    Article  CAS  Google Scholar 

  6. Yanes-Lane M, Winters N, Fregonese F, Bastos M, Perlman-Arrow S, Campbell JR, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and meta-analysis. PLoS ONE. 2020;15(11): e0241536.

    Article  CAS  Google Scholar 

  7. Wu Z, Harrich D, Li Z, Hu D, Li D. The unique features of SARS-CoV-2 transmission: comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus. Rev Med Virol. 2021;31(2): e2171.

    Article  CAS  Google Scholar 

  8. Zhang W, Cheng W, Luo L, Ma Y, Xu C, Qin P, et al. Secondary transmission of coronavirus disease from presymptomatic persons, China. Emerg Infect Dis. 2020;26(8):1924.

    Article  CAS  Google Scholar 

  9. Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci. 2020;117(30):17513–5.

    Article  CAS  Google Scholar 

  10. Foundation TH. COVID-19 policy tracker: DHSC publishes a prioritisation list for COVID-19 tests that includes hospital patients, care home residents and staff and NHS staff. 2022.

    Google Scholar 

  11. Foundation TH. COVID-19 policy tracker: Government announces roll-out of two rapid tests for COVID-19 that will be made available to NHS hospitals, care homes and labs across the UK. 2022.

    Google Scholar 

  12. Penuliar M, Clark C, Curti D, Hudson C, Philips B. Universities and COVID-19 Growth at the Start of the 2020 Academic Year. medRxiv. 2020.

  13. Cohen JF, Korevaar DA, Matczak S, Brice J, Chalumeau M, Toubiana J. COVID-19-related mortality by age groups in Europe: a meta-analysis. MedRxiv. 2020.

  14. Nixon EJ, Trickey A, Christensen H, Finn A, Thomas A, Relton C, et al. Contacts and behaviours of university students during the COVID-19 pandemic at the start of the 2020/21 academic year. medRxiv. 2020.

  15. Brook CE, Northrup GR, Ehrenberg AJ, Doudna JA, Boots M, Consortium ITCTIT. Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment. medRxiv. 2020.

  16. Cambridge Uo. Asymptomatic COVID-19 screening programme 2020 [Available from:

  17. Nottingham Uo. University of Nottingham Testing Service: Test to protect 2020 [Available from:

  18. E. B. Covid ‘nearly eliminated’ on UK campus after asymptomatic testing: Times Higher Education 2020. Available from: [Updated 16 Dec 2020]. 

  19. Southampton Uo. Regular saliva testing to be trialled in University and Southampton schools 2020. Available from: [Updated 3 Sep 2020].

  20. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic acids research. 2000;28(12):e63.

    Article  CAS  Google Scholar 

  21. Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. 2020;8(12):1192–200.

    Article  CAS  Google Scholar 

  22. Howson EL, Kidd SP, Armson B, Goring A, Sawyer J, Cassar C, et al. Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP). J Virol Methods. 2021;289: 114048.

    Article  CAS  Google Scholar 

  23. Diagnostics E. PrimeStore MTM - A novel viral transport media for infectious diseases 2021. Available from:

  24. Rabe BA, Cepko C. SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification. Proc Natl Acad Sci. 2020;117(39):24450–8.

    Article  CAS  Google Scholar 

  25. Allsopp R, Cowley C, Barber R, Jones C, Holmes C, Bird P, et al. Rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission. 2022.

    Google Scholar 

  26. Government U. Coronavirus cases by local authority: epidemiological data 2020. Available from: [Updated 30 Oct 2020]

  27. Statistics OfN. How has coronavirus (COVID-19) spread among students in England? 2020. Available from: [Updated 21 Dec 2020.

  28. University of Liverpool. Liverpool COVID-19 community testing pilot: interim evaluation report summary. GOV.UK. Available from: Accessed 10 Mar 2021.

  29. Gillam TB, Cole J, Gharbi K, Angiolini E, Barker T, Bickerton P, et al. Norwich COVID-19 testing initiative pilot: evaluating the feasibility of asymptomatic testing on a university campus. J Public Health. 2021;43(1):82–8.

    Article  Google Scholar 

  30. Committee UNS. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme 2015 [updated 23 October 2015. Available from:

Download references


This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

The Screening Programme for Autumn Term 2020 was supported by core funding from the University of Leicester.

Assay validation was supported by Leicester Drug Discovery and Diagnostics using MRC Confidence in Concept Award funds (MRC Award number MC- MC_PC_18054).

ALH acknowledges funding from the NIHR HPRU in Environmental Exposures and Health at the University of Leicester, a partnership between UK Health Security Agency and the University of Leicester. The views expressed are those of the author(s) and not necessarily those of the NIHR, UK Health Security Agency or the Department of Health and Social Care.

MDT is supported by a Wellcome Trust Investigator Award (WT202849/Z/16/Z), and an NIHR Senior Investigator Award, and is partially supported by the NIHR Leicester Biomedical Research Centre; the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

Author information

Authors and Affiliations



CB, RA, JS and MT were involved in the initial design and ongoing implementation, with AH providing additional input in programme design and support. NB and PB provided steering for the project, with GH providing project management. CC and RA implemented the university laboratory RT-LAMP testing and CH implemented the RT-PCR testing. RB provided operational management of the programme. CB drafted the manuscript, with all other authors reviewing and offering feedback. RA and CC are able to verify the underlying data. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Claire Blackmore.

Ethics declarations

Ethics approval and consent to participate

No ethical approval was required as the study was conducted as a clinical service evaluation of a new service being introduced, working with local primary care.

We did not seek ethical approval as service evaluations are exempt from the ethical approval process, and so there is no Ethics Committee or Institutional Board involved.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

 Figure 1. Layout of testing centre, detailing testing booths and placement of testing equipment. Figure 2. Photo of individual testing booth and setup of equipment required. 

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blackmore, C., Hall, G.W., Allsopp, R.C. et al. How to design and implement a university-based COVID-19 testing programme? An evaluation of a novel RT-LAMP COVID-19 testing programme in a UK university. BMC Health Serv Res 22, 1502 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: